New hires and promotions in the biopharma industry, including: Aclaris, Adverum, Allero, Alpine, Athira, Cidara, Iovance, Logicbio, Neurocytonix, Nodthera, Nouscom, Oncorus, Precision, Rhythm, Sarepta, Silo, Springworks, X4.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avelas Biosciences, Foldax.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Activepure Technologies, Aditx Therapeutics, American Bio Medica, Ashvattha Therapeutics, Babylon Health, Builtspace, Diabeloop, Efemoral Medical, Eurofins Technologies, GE Healthcare, Hummingbird Bioscience, Insightec, Lifescan, Luminultra, Mymedbot, Novacyt, Novocure, Oncimmune, Pacific Biosciences, Roche, SonALAsense, Tempus Labs, Todos Medical, Variscite, Welldoc.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Masimo, Memed, Theradiag, Theranica.

Med-tech firms raising money in public or private financings, including: Adapthealth, Pavmed, Well Dot.

New hires and promotions in the med-tech industry, including: Axonics, Edigene, Envision Healthcare, Guardant Health, Robocath, Tandem Diabetes Care.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Acceleron, Amag, Ascletis, Antengene, Astrazeneca, Avelas, Biontech, Codagenix, Daiichi Sankyo, EMD, Gamida, Gannex, Graphite, Legend, Merck KGaA, Mindmed, Open Orphan, Pfizer, Sobi.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3Sbio, ADC, Adelia, Allarity, Alzecure, Anixa, Ascentage, Ashvattha, Brainstorm Cell, Crispr, Cybin, Enzolytics, Eureka, Havn, Hemab, Hummingbird, Immuno-Precise, Intellia, Litevax, Mosaic, Neuraxpharm, Neurorx, Novo Nordisk, Overland, Pharmacyte, Phathom, Reviva, Spectrum, Teon, Unicycive, Verseau, Vivus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aerpio, Amarin, Arvinas, Astrazeneca, Bellus, Biontech, Biophytis, Caladrius, Cytokinetics, Curevac, Daiichi, Freeline, Innovent, Junshi, Kintor, Lilly, Mitsubishi Tanabe, Novartis, Odonate, Pfizer, Polyphor, Poxel, Puma, RDIF, Sanofi, Synlogic, TCR2.

Biopharmas raising money in public or private financings, including: 9 Meters, Curis, Hookipa, IGM, Kura, Locanabio, Mirum.